Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 45.

Gerbase, M W; Dupuis-Lozeron, E; Schindler, C; Keidel, D; Bridevaux, P O; Kriemler, S; Probst-Hensch, N M; Rochat, T; Künzli, N (2013). Agreement between spirometers: a challenge in the follow-up of patients and populations? Respiration, 85(6):505-514.

Albinger-Hegyi, A; Stoeckli, S J; Schmid, S; Storz, M; Iotzova, G; Probst-Hensch, N M; Rehrauer, H; Tinguely, M; Moch, H; Hegyi, I (2010). Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC). International Journal of Cancer, 126(11):2653 -2662.

Leuenberger, M; Frigerio, S; Wild, P J; Noetzli, F; Korol, D; Zimmermann, D R; Gengler, C; Probst-Hensch, N M; Moch, H; Tinguely, M (2010). AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations. Modern Pathology, 23(2):177-186.

Riener, M O; Fritzsche, F R; Soll, C; Pestalozzi, B C; Probst-Hensch, N M; Clavien, P A; Jochum, W; Soltermann, A; Moch, H; Kristiansen, G (2010). Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas. Histopathology, 56(5):600-606.

Curjuric, I; Imboden, M; Schindler, C; Downs, S H; Hersberger, M; Liu, S L J; Matyas, G; Russi, E W; Schwartz, J; Thun, G A; Postma, D S; Rochat, T; Probst-Hensch, N M (2010). HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reduction. European Respiratory Journal, 35(3):505-514.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Imboden, M; Schwartz, J; Schindler, C; Curjuric, I; Berger, W; Liu, S L; Russi, E W; Ackermann-Liebrich, U; Rochat, T; Probst-Hensch, N M (2009). Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect. Environ Health Perspect, 117(9):1420-1427.

Bridevaux, P O; Gerbase, M W; Schindler, C; Felber Dietrich, D; Curjuric, I; Dratva, J; Ackermann-Liebrich, U; Probst-Hensch, N M; Gaspoz, J M; Rochat, T (2009). Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2. European Respiratory Journal, 34(2):332-339.

Dratva, J; Gómez Real, F; Schindler, C; Ackermann-Liebrich, U; Gerbase, M W; Probst-Hensch, N M; Svanes, C; Omenaas, E R; Neukirch, F; Wjst, M; Morabia, A; Jarvis, D; Leynaert, B; Zemp, E (2009). Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies. Menopause, 16(2):385-394.

Riener, M O; Stenner, F; Liewen, H; Soll, C; Breitenstein, S; Pestalozzi, B C; Samaras, P; Probst-Hensch, N M; Hellerbrand, C; Müllhaupt, B; Clavien, P A; Bahra, M; Neuhaus, P; Wild, P; Fritzsche, F; Moch, H; Jochum, W; Kristiansen, G (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 49(5):1602 -1609.

Ceschi, M; Probst-Hensch, N M (2009). Aufgaben und Ziele eines modernen Krebsregisters. In: Krebs im Kanton Zürich. Ein Bericht des Krebsregisters. Zürich: Institut für Sozial- und Präventivmedizin der Universität Zürich, 5-12.

Ceschi, M; Bopp, M; Probst-Hensch, N M (2009). Bedeutung der Krebskrankheiten im Kanton Zürich. In: Krebs im Kanton Zürich. Ein Bericht des Krebsregisters. Zürich: Institut für Sozial- und Präventivmedizin der Universität Zürich, 21-30.

Ceschi, M; Probst-Hensch, N M (2009). Erfassung und Registrierung der Krebsfälle im Kanton Zürich. In: Krebs im Kanton Zürich. Ein Bericht des Krebsregisters. Zürich: Institut für Sozial- und Präventivmedizin der Universität Zürich, 13-16.

Ackermann-Liebrich, U; Schindler, C; Frei, P; Probst-Hensch, N M; Imboden, M; Gemperli, A; Rochat, T; Schmid-Grendemeier, P; Bircher, A J (2009). Sensitisation to Ambrosia in Switzerland: a public health threat on the wait. Swiss Medical Weekly, 139(5-6):70-75.

Ceschi, M; Bopp, M; Probst-Hensch, N M (2009). Spezifische Krebslokalisationen. In: Krebs im Kanton Zürich. Ein Bericht des Krebsregisters. Zürich: Institut für Sozial- und Präventivmedizin der Universität Zürich, 31-82.

Soltermann, A; Tischler, V; Arbogast, S; Braun, J; Probst-Hensch, N M; Weder, W; Moch, H; Kristiansen, G (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research, 14(22):7430-7437.

Clifford, G M; Rickenbach, M; Polesel, J; Dal Maso, L; Steffen, I; Ledergerber, B; Rauch, A; Probst-Hensch, N M; Bouchardy, C; Levi, F; Franceschi, S (2008). Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS, 22(16):2135-2141.

Senn, O; Russi, E W; Schindler, C; Imboden, M; von Eckardstein, A; Brändli, O; Zemp, E; Ackermann-Liebrich, U; Berger, W; Rochat, T; Luisetti, M; Probst-Hensch, N M (2008). Circulating alpha1-antitrypsin in the general population: determinants and association with lung function. Respiratory Research, 9:35.

Tinguely, M; Jenni, B; Knights, A; Lopes, B; Korol, D; Rousson, V; Curioni Fontecedro, A; Cogliatti, S B; Bittermann, A G; Schmid, U; Dommann-Scherrer, C; Maurer, R; Renner, C; Probst-Hensch, N M; Moch, H; Knuth, A; Zippelius, A (2008). MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer Science, 99(4):720-725.

Mertz, K D; Demichelis, F; Sboner, A; Hirsch, M S; Cin, P D; Struckmann, K; Storz, M; Scherrer, S; Schmid, D M; Strebel, R T; Probst-Hensch, N M; Gerstein, M; Moch, H; Rubin, M A (2008). Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. International Journal of Cancer, 123(3):569-576.

Felber Dietrich, D; Ackermann-Liebrich, U; Schindler, C; Barthélémy, J C; Brändli, O; Gold, D R; Knöpfli, B; Probst-Hensch, N M; Roche, F; Tschopp, J M; von Eckardstein, A; Gaspoz, J M (2008). Effect of physical activity on heart rate variability in normal weight, overweight and obese subjects: results from the SAPALDIA study. European Journal of Applied Physiology, 104(3):557-565.

Imboden, M; Rochat, T; Brutsche, M; Schindler, C; Downs, S H; Gerbase, M W; Berger, W; Probst-Hensch, N M (2008). Glutathione S-transferase genotype increases risk of progression from bronchial hyperresponsiveness to asthma in adults. Thorax, 63(4):322-8.

Probst-Hensch, N M; Imboden, M; Felber Dietrich, D; Barthélémy, Jean Claude; Ackermann-Liebrich, U; Berger, W; Gaspoz, Jean-Michel; Schwartz, J (2008). Glutathione S-transferase polymorphisms, passive smoking, obesity, and heart rate variability in nonsmokers. Environmental Health Perspectives, 116(11):1494-1499.

Wong, H L; Koh, W P; Probst-Hensch, N M; Van den Berg, D; Yu, M C; Ingles, S A (2008). Insulin-like growth factor-1 promoter polymorphisms and colorectal cancer: a functional genomics approach. Gut, 57(8):1090-1096.

Bridevaux, P O; Gerbase, M W; Probst-Hensch, N M; Schindler, C; Gaspoz, J M; Rochat, T (2008). Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax, 63(9):768-774.

Polesel, J; Clifford, G M; Rickenbach, M; Dal Maso, L; Battegay, M; Bouchardy, C; Furrer, H; Hasse, B; Levi, F; Probst-Hensch, N M; Schmid, P; Franceschi, S (2008). Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, 22(2):301-306.

Moch, H; Komminoth, P; Zimmermann, D R; Odermatt, B; Probst-Hensch, N M; Bopp, M (2008). Pathologie: Aufgaben und Methoden. In: Böcker, W; Denk, H; Heitz, P U. Pathologie. München, Jena: Urban und Fischer bei Elsevier, 3-34.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Storz, M; Probst-Hensch, N M; Seifert, Burkhardt; Fehr, M K; Fink, D; Ferrone, S; Pestalozzi, B; Jungbluth, A A; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunology, Immunotherapy, 56(11):1723-1731.

Imboden, M; Downs, S H; Senn, O; Matyas, G; Brändli, O; Russi, E W; Schindler, C; Ackermann-Liebrich, U; Berger, W; Probst-Hensch, N M (2007). Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respiratory Research, 8:2.

Ceschi, M; Gutzwiller, Felix; Moch, H; Eichholzer, Monika; Probst-Hensch, N M (2007). Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Medical Weekly, 137(3-4):50-56.

Franceschi, S; Polesel, J; Rickenbach, M; Dal Maso, L; Probst-Hensch, N M; Fux, C; Cavassini, M; Hasse, B; Kofler, A; Ledergerber, B; Erb, P; Clifford, G M (2006). Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. British Journal of Cancer, 95(11):1598-1602.

Nitsch, D; Felber Dietrich, D; von Eckardstein, A; Gaspoz, J M; Downs, S H; Leuenberger, P; Tschopp, J M; Brändli, O; Keller, R; Gerbase, M W; Probst-Hensch, N M; Stutz, E Z; Ackermann-Liebrich, U (2006). Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrology, Dialysis, Transplantation, 21(4):935-944.

Imboden, M; Nieters, A; Bircher, Aj; Brutsche, M; Becker, N; Wjst, M; Ackermann-Liebrich, U; Berger, W; Probst-Hensch, N M; Sapaldia Team (2006). Cytokine gene polymorphisms and atopic disease in two European cohorts. (ECRHS-Basel and SAPALDIA). Clinical and Molecular Allergy : CMA, 4:9.

Imboden, M; Nicod, L; Nieters, A; Glaus, E; Matyas, G; Bircher, A J; Ackermann-Liebrich, U; Berger, W; Probst-Hensch, N M (2006). The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study. Clinical and Experimental Allergy, 36(2):211-8.

Probst-Hensch, N M; Sun, C L; Van Den Berg, D; Ceschi, M; Koh, W P; Yu, M C (2006). The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis, 27(12):2475-2482.

Senn, O; Russi, E W; Imboden, M; Probst-Hensch, N M (2005). alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants. European Respiratory Journal, 26(5):909-917.

Ackermann-Liebrich, U; Kuna-Dibbert, B; Probst-Hensch, N M; Schindler, C; Felber Dietrich, D; Stutz, E Z; Bayer-Oglesby, L; Baum, F; Brändli, O; Brutsche, M; Downs, S H; Keidel, D; Gerbase, M W; Imboden, M; Keller, R; Knöpfli, B; Künzli, N; Nicod, L; Pons, M; Staedele, P; Tschopp, J M; Zellweger, J P; Leuenberger, P (2005). Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants. Sozial- und Präventivmedizin, 50(4):245-263.

Gunter, M J; Probst-Hensch, N M; Cortessis, V K; Kulldorff, M; Haile, R W; Sinha, R (2005). Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case-control study. Carcinogenesis, 26(3):637-642.

Heitz, P U; Komminoth, P; Zimmermann, D; Probst-Hensch, N M; Bopp, M (2004). Aufgaben der Pathologie. In: Böcker, W. Lehrbuch Pathologie. München: Urban & Fischer Verlag, 5-37.

Ohgaki, H; Dessen, P; Jourde, B; Horstmann, S; Nishikawa, T; Di Patre, P L; Burkhard, C; Schüler, D; Probst-Hensch, N M; Maiorka, P C; Baeza, N; Pisani, P; Yonekawa, Y; Yasargil, M G; Lütolf, U M; Kleihues, P (2004). Genetic pathways to glioblastoma: a population-based study. Cancer Research, 64(19):6892-6899.

Zwahlen, M; Bopp, M; Probst-Hensch, N M (2004). Mammography screening in Switzerland: limited evidence from limited data. Swiss Medical Weekly, 134(21-22):295-306.

Faisst, Karin; Probst-Hensch, N M (2004). Pharmakogenetische Tests in der ärztlichen Praxis. Schweizerische Ärztezeitung, 85(37):1975-1977.

Okamoto, Y; Di Patre, P L; Burkhard, C; Horstmann, S; Jourde, B; Fahey, M; Schüler, D; Probst-Hensch, N M; Yasargil, M G; Yonekawa, Y; Lütolf, U M; Kleihues, P; Ohgaki, H (2004). Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathologica, 108(1):49-56.

Probst-Hensch, N M; Wang, H; Goh, V H H; Seow, A; Lee, H-P; Yu, M C (2003). Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiology Biomarkers & Prevention, 12(8):739-746.

DeLellis, K; Ingles, S; Kolonel, L; McKean-Cowdin, R; Henderson, B; Stanczyk, F; Probst-Hensch, N M (2003). IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. British Journal of Cancer, 88(2):277-282.

This list was generated on Wed Nov 22 13:31:18 2017 CET.